Understanding influenza vaccination rates and reasons for refusal in caregivers and household contacts of cancer patients

Price, Stephanie; Podczervinski, Sara; MacLeod, Kim; Helbert, Lois; Pergam, Steven A.

doi:10.1016/j.ajic.2018.10.010

Cited by 9 publications

(5 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A 2019 study in the USA investigated the influenza vaccination status of oncological patients and their caregivers [31]. The vaccination rate among patients was 72% and among caregivers 71%.…”

Section: Discussionmentioning

confidence: 99%

Cocoon vaccination for influenza in patients with a solid tumor: a retrospective study

Rensink

Laarhoven

Holleman

2020

Support Care Cancer

View full text Add to dashboard Cite

Purpose Oncological patients are susceptible to various severe viral infections, including influenza. Vaccinating oncological patients and their household contacts (“cocoon vaccination”) may protect these patients from contracting influenza. To understand the potential of cocoon vaccination in oncological patients, this study assesses the influenza vaccination status of oncological patients and their household contacts and their considerations regarding the vaccination. Methods In this retrospective study, oncological patients with a solid tumor were asked to fill in a questionnaire about their own and their household contacts’ influenza vaccination status in the influenza season of 2018–2019. Results Ninety-eight patients were included (response rate 88%). The influenza vaccination rates of oncological patients and their first household contacts were 43.9% and 44.9%, respectively. The majority of vaccinated patients and vaccinated first household contacts had been advised by their general practitioner to get the vaccination. A minority of the first household contacts reported getting vaccinated specifically because of the patient’s vulnerability. Unvaccinated patients and unvaccinated household contacts mainly believed the vaccination was unnecessary or were afraid of side effects. None of the included patients had been hospitalized with influenza. Conclusion The oncological patients’ and first household contacts’ vaccination rates in this study were lower than the vaccination rates of the general Dutch population of over 60 years old, possibly due to a lack of knowledge and misconceptions about the vaccination. Further research is required to establish whether cocoon vaccination can contribute to protecting oncological patients from contracting an influenza infection.

show abstract

Section: Discussionmentioning

confidence: 99%

Cocoon vaccination for influenza in patients with a solid tumor: a retrospective study

Rensink

Laarhoven

Holleman

2020

Support Care Cancer

View full text Add to dashboard Cite

show abstract

“…As some easily transmitted, vaccine-preventable illnesses can be life-threatening, especially in immunosuppressed or immunocompromised patients (e.g. measles, chickenpox, influenza), the most senior doctor and nurse, infection control specialist and the occupational medical service should work intensively together to ensure that, where possible, all non-immune members of the treatment team get vaccinated against these illnesses [ 82 ], [ 83 ], [ 84 ]. This is an important task for the hospital administration [ 85 ].…”

Section: Recommendationsmentioning

confidence: 99%

Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute

2022

View full text Add to dashboard Cite

In Germany, guidelines for hygiene in hospitals are given in form of recommendations by the Commission for Hospital Hygiene and Infection Prevention (Kommission für Krankenhaushygiene und Infektionsprävention, “KRINKO”). The KRINKO and its voluntary work are legitimized by the mandate according to § 23 of the Infection Protection Act (Infektionsschutzgesetz, “IfSG”). The original German version of this document was published in February 2021 and has now been made available to the international professional public in English. The guideline provides recommendations on infection prevention and control for immunocompromised individuals in health care facilities. This recommendation addresses not only measures related to direct medical care of immunocompromised patients, but also management aspects such as surveillance, screening, antibiotic stewardship, and technical/structural aspects such as patient rooms, air quality, and special measures during renovations.

show abstract

“…It is critical to remember that N- 95 spaces where patients cohort together [15]. As discussed above, efforts to assure high-level influenza vaccine compliance and dedicated vaccination campaigns among healthcare workers and families/caregivers can also provide additional protection for high risk patients [225,226]. Furthermore, dedicated educational efforts targeted towards patients and their caregivers to promote active hand hygiene, appropriate respiratory hygiene, and awareness of the risks of respiratory viruses are important.…”

Section: Infection Control Practices To Protect Transplant Patients From Respiratory Virusesmentioning

confidence: 99%

Respiratory Viral Pathogens in Solid Organ and Hematopoietic Stem Cell Transplant Recipients

Pergam

Ison

2020

Emerging Transplant Infections

Self Cite

View full text Add to dashboard Cite

Understanding influenza vaccination rates and reasons for refusal in caregivers and household contacts of cancer patients

Cited by 9 publications

References 10 publications

Cocoon vaccination for influenza in patients with a solid tumor: a retrospective study

Cocoon vaccination for influenza in patients with a solid tumor: a retrospective study

Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute

Respiratory Viral Pathogens in Solid Organ and Hematopoietic Stem Cell Transplant Recipients

Contact Info

Product

Resources

About